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This is a description in some detail of the sensitized sheep cell hemagglu-
tination test for rheumatoid arthritis as it is currently carried out in this
Clinic. Sustained interest in the pathogenesis, natural history, and treat-
ment of rheumatoid arthritis leads us to direct a significant portion of the
investigative studies toward improvements in the serological method with
fairly exact definition of its diagnostic and prognostic value.
A lengthy test and the vagaries of rheumatoid arthritis suggest that the
description of the method and its evaluation be treated separately. The
poorly defined clinical landmarks of rheumatoid arthritis do indicate the
need for such a diagnostic test. It is when the limits of clinical discernment
and serological accuracy are mutually established that both can be used to
full advantage. This report is rather strictly confined to the actual pro-
cedure. Data at hand will supply the material for its clinical counterpart.
Meanwhile, Table 1 and a recent publication2 tell something of the
performance of the hemagglutination test in rheumatoid arthritis.
MATERIALS AND METHOD
MATERIALS. 1. Sheep red cells. The sheep erythrocytes are obtained commercially as
blood from a single sheep in an equal amount of citrate. The supply, which is received
weekly, is refrigerated at 4° C. for a maximum of one month. The donor differs from
week to week. Red cells are washed in saline at least three times. Packed volume
under the clear supernatant is measured after centrifugation at 2,000 r.p.m. for 20
minutes. The preparation and resuspension of cells are arranged to coincide with the
time of use. Twenty-five per cent red cells are obtained by direct dilution. The 1.0
per cent suspension is prepared by redilution of 10 per cent red cells.
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2. Diluent. Isotonic (0.89 per cent) saline is the diluent in all instances. Phosphate
buffered solutions of a limited acid to alkaline range (pH 6.5, 7.0, and 7.8) are
without value.
3. Rabbit anti-sheep cell serum. This glycerinated hemolysin (equal parts of
glycerin and hemolysin) is also obtained from a commercial source. A 1: 100 dilution
is prepared as needed. Both the original supply and the stock dilution are stored at
-10° C. The diluted hemolysin is discarded at the end of one week.
4. Glassware. Standard tubes (10 x 75 mm.) are used for the human serum
throughout the method. Corks are included for storage.
METHOD. 1. Absorption of heterophile (naturally occurring) agglutinins.
To 0.4 ml. of human serum (inactivated at 560 C. for 30 minutes) is added
0.8 ml. of a 25 per cent sheep cell suspension. The tube (10 x 75 mm.
dimensions) is shaken and allowed to stand at room temperature for 15
minutes. It is shaken again and centrifuged at 2,000 r.p.m. for 10 minutes.
Another 0.8 ml. of cell suspension is added to the supernatant and the
tube shaken. The absorption process is thus repeated for an additional 15
minutes at room temperature followed by refrigeration at 4° C. overnight
or for a minimum of one hour if the serum is to be used the same day. The
suspension is shaken and centrifuged. The absorbed serum, now in a 1: 4
dilution, is removed and used in the test or kept frozen at -10° C. The
amount of easily removed serum is adequate for a repeat test, if needed.
A newer and less involved technique is the addition of 1.6 ml. of a 25 per
cent sheep cell suspension to the 0.4 ml. of inactivated serum. The tube is
shaken for a full minute and refrigerated. Absorption is started during the
morning or early afternoon so that time allows a second and similar agita-
tion. Centrifugation directly follows the overnight refrigeration.
Both methods are current. The latter is now routine, and the former is
available when more than usual promptness is demanded. Information on
the adequacy of both is included in the general discussion of the hemagglu-
tination test which follows.
2. Titration of hemolysin. The dilution of hemolysin for the clinical test
is established for each shipment of sheep cells. The desired amount is that
which will agglutinate the cells at the established titer of the positive serum
and clearly fail to cause agglutination in the normal serum. It is constant
for each lot of cells but differs with the donor and even with the blood of
the same sheep at another time. Two human serums are used. The one of
known high titer is obtained from a patient with active rheumatoid arthri-
tis, and the other is from an apparently healthy individual. The inactivated
and absorbed control serums are from almost constant sources and are
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stored at -10° C. For convenience, a sample of the high titer serum for
current use is diluted to one-fourth of its titer and kept frozen.
Two sets of tubes are arranged in racks to contain five rows of four each.
One set is used for each control serum. Three-tenths ml. of saline is added
to the tubes. Serum in like quantity is placed in the first tube of each set.
It is mixed and 0.3 ml. is carried by a pipette from tube to tube. The two-
fold serial dilutions of the normal serum are from 1: 8 through 1: 64 and
those of the rheumatoid serum from 1: 64 through 1: 512. There are no
control tubes since completeness of absorption was confirmed at an earlier
time.
Five dilutions of the stock (1: 100) hemolysin are usual. Concentrations
are in the even numbers of 1: 4,000 through 1: 12,000. An additional tube
(1: 14,000) is occasionally indicated by recorded titrations with cells from
a certain sheep. Experience allows ready interpolation to the nearest one
thousand and a finer expression of hemolysin dilution is not considered
practical.
Two milliliter amounts of 1.0 per cent red cells in saline are sensitized
by addition to an equal aliquot of each dilution of hemolysin. The mixture
is incubated in a water bath at 37.5° C. for 15 minutes and 0.3 ml. of even
suspension is pipetted into each of the eight tubes. Thorough agitation of
the racks is directly followed by overnight refrigeration. Incubation at
37.5° C. for one hour is no longer employed since the slight increase in
titer is obtained at the expense of sharpness of pattern.
The desired pattern in both serums should be obtained without difficulty
as the amount of hemolysin should not be so critical that some leeway does
not exist. Sheep cells which are unsatisfactory are reserved for the absorp-
tion of serums, and re-titration includes the cells of another sheep. The
results are regularly reproduced in the actual test where the two standard
serums are again used.
3. Clinical test. A row of nine tubes is used for each sample of inacti-
vated and absorbed serum. Saline in 0.3 ml. amounts is added to the last
eight tubes. Three-tenths milliliters of patient's serum is placed in both the
first and second tubes. It is mixed in the second tube and carried to pro-
duce twofold dilutions from 1: 8 through 1: 1,024. The first tube of a row
contains serum in a 1: 4 dilution for the detection of incomplete removal of
heterophile antibodies. Dilutions of the two standard serums are limited
to four.
Sheep cells are sensitized by adding an equal volume of 1.0 per cent red
cells to hemolysin of a concentration set by the titration. This mixture of
0.5 per cent cells in diluted hemolysin is placed in a water bath at 37.5° C.
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arthritis. The normal pattern of settled cells in nonrheumatoid (n) and usual back-
ground in rheumatoid (N) serums are shown. Clumping at periphery of patterns is
recorded at 1 plus through 4 plus. Titer of serum is the highest dilution in which
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for 15 minutes, and then 0.3 ml. of the uniform suspension is added to the
last eight tubes of each row. The first tubes (control) receive a like amount
of unsensitized cells in a dilution of 0.5 per cent. The racks of tubes are
well shaken and refrigerated overnight. The appearance of the settled red
cells determines the titer and result. Checks on adequacy of absorption and
correctness in the amount of hemolysin are supplied by the control tubes
and dual standards. These with the serums under study complete a routine
test.
4. Results. The appearance of the settled red cells determines the test
result (Fig. 1). Titer is expressed in units as the reciprocal of serum dilu-
tion. A range of less than eight units through 1,024 units is usually more
than adequate for testing. The positive and negative standard serums must
give the expected reactions and adequate removal of heterophile agglutinins
shown.
Patterns are observed effectively from below by holding the tilted tube
(about 40 degrees) at eye level against good light. The typical "negative"
pattern is compact and usually sharply defined. It best presents as a small
red disc in the control tube when absorption is complete. In tubes contain-
ing sensitized cells the disc is usually larger and has a light center of
varying size.
Reactions are graded one through four according to the extent of dis-
tortion at the periphery. The basic positive pattern is a thin film of cells
which covers the bottom of the tube. Clumping of red cells to form a side
is a one plus, and a square is a four plus. Two- and three-sided figures give
the intermediate grades of two plus and three plus. These are the usual
designs. Hexagons, pentagons, and triangles are assigned a four plus since
there is complete loss of circular form. Clumping at the circumference of an
N pattern is a one or two plus according to degree. The N or basic positive
pattern and cupping with a less than linear distortion are recorded but are
not yet used as the endpoint. Their inclusion will further increase titer
and yet maintain specificity. In practice, a reaction of one plus or more
places the titer, and a titer of eight units is a positive test.
DISCUSSION
The hemagglutination test for rheumatoid arthritis is described at some
length from titration of the reagents to interpretation of results. This par-
ticular method has been in active use for over two years. Experience with
the various modifications of the test extends over a longer but less continu-
ous period of time. These modifications were originally used in the screen-
ing search for a single basic and fairly sensitive test. They are again
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encountered by necessity in the evaluation of recent highly encouraging
refinements8"'5 by others. Modifications occur naturally in the develop-
ment of a test and lead to improvement. They can be too numerous, and a
cumulative effect is felt when the new methods are imposed on diverse
ones. A standard basic method permits ready evaluation of these promising
refinements which deal principally with fractions of serum rather than
whole serum.
The method as described detects the agglutination of sheep cells by
settled pattern rather than by agitation. This is a more effective means
since the titers of rheumatoid patients are unchanged or increased, while
the serums of most nonrheumatoid individuals will fail to react within the
visual range of the test. This is more than a matter of personal preference
since the real range of the test becomes extended by the inclusion of the
lower and now significant titers.
The total effects are not in conflict since less hemolysin is needed. It is
the efforts to increase sensitivity by use of more hemolysin that have been
ineffectual through an inordinate loss of specificity. This is apparent from
the direct comparison of methods. It is expressed in a somewhat different
way in the study of Alexander and de Forest.1 Incidence of positive tests
(64 units and more) was 75 per cent in rheumatoid patients. Selection of
a titer of 1: 16 (16 units) as the line of demarcation increased the per cent
to 88 but positive tests appeared in individuals with osteoarthritis to the
extent of 20 per cent.
This present method is suggested as a standard method. High selectivity
is obtained without apparent alteration of the basic factors. Its nature sug-
gests that more of the total mechanism is open to inspection. Both quality
and consistency are important for accuracy in the appraisal of promising
refinements.
The few other changes in the hemagglutination test are of a streamlining
nature. The absorption procedure is the most effectual timesaver of all.
Failure to remove adequately heterophile antibodies is so unusual that no
effort is made to supply comparative figures. The following facts are imme-
diately available. Absorption was incomplete in one of the serums from 121
recent patients (first method with refrigeration for two hours). This in-
cidence of less than one per cent is known to be high. Removal was com-
plete from all serums of 203 patients in a later group (second method).
The treatment of exceptional serums is not yet uniform because of their
infrequency and the efficacy of the usual means at hand. The process may
be started anew with another 0.4 ml. sample of inactivated serum. Agitation
and refrigeration is lengthened. A new lot of sheep cells is at times used.
This means is usually preferred since the method remains constant. Time
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and inadequacy of serum would favor the alternative of an addition of
0.8 ml. of cells to 0.6 ml. of the partially absorbed serum. The regular dilu-
tions are maintained quite readily. There is loss of a safety factor since the
concentration of serum in the control tube and first tube of the test is the
same (1: 8).
Although serum is used with continuing regularity in this laboratory,
reference should be made to the use of plasma in the test. The following
comparison was prompted in part by an early situation where only an
oxalated sample of blood was available for the determination. The sources
of plasma and serum for the parallel tests were 29 patients and 5 healthy
adults. The patients were clinically distributed as: rheumatoid arthritis, 20;
rheumatoid arthritis with psoriasis, 1; osteoarthritis, 7; and gout, 1. Those
with rheumatoid arthritis included four whose tests had returned to nega-
TABLE 1. THE HEMAGGLUTINATION TEST IN RHEUMATOID ARTHRITIS AND IN
NONRHEUMATOID ILLNESSES (200 ADULTS)
Number of Hemagglutination test
Clinical impression patients Positive Negative
Rheumatoid arthritis 100 91 9
Other illnesses 100 2 98
tive and one with only negative tests on record. The titers of plasma and
serum matched in 32 instances. Two individuals with rheumatoid arthritis
had plasma titers of 512 units and serum titers of 256 units. There was no
shift of result from negative to positive even with the five rheumatoid
patients. For these and other reasons, the increase is without import.
Neither absorption nor red cell pattern was affected. This is evidence that
in usual laboratory practice plasma and serum can be used quite inter-
changeably as dictated by convenience or need.
Table 1 summarizes with minimal detail the results of the hemagglutina-
tion test in 200 patients. It is included since strict adherence to method may
be unduly limiting in this discussion of a clinical test. Attention is called to
the manner of selection of the patients. The primary source was the files of
the Streptococcus laboratory which include many with rheumatic diseases.
Clinical behavior of the test is assessed from the results in well-established
illnesses, both rheumatoid and nonrheumatoid. The number in each group
was limited to 100 adults. The rheumatoid patients have "textbook" rheu-
matoid arthritis and the result of the hemagglutination test tabulated is that
of the initial determination. Similarly, the individuals in the control group
have an accurately defined presenting illness without overt rheumatoid
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arthritis. This should result in approximate information on sensitivity and
selectivity with a somewhat high incidence of positive tests in both groups.
The data in Table 1 place the diagnostic effectiveness of the hemagglu-
tination test at about 90 per cent (189 of 200 patients). Information
obtained from other studies in this clinic indicates that the figures have a
broad validity. The failure of the method to support the clinical impression
in the 11 patients lacks full explanation.
SUMMARY
The hemagglutination test for rheumatoid arthritis as described offers
the high selectivity and sharp results which are requirements for a practical
test. It should serve as a satisfactory standard method for new and special
refinements.
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